Leadership/Faculty/Staff
Research Programs
Clinical Trials/Studies
Referral Information
Travel/Local Information
Support Programs/Services
Educational Programs
The Power of Giving
Make a Donation
Online Shopping
Fundraising Events
Faces of Hope
Journey of Hope
Voices of Hope
Family Scrapbook
Mission and History
Careers
Board of Advisors
Community Partners
In the News
|
|
 Photo courtesy of Duke University Medical Center
|
Allan H. Friedman, MD
—The Guy L. Odom Professor of Neurological Surgery —Deputy Director, The Preston Robert Tisch Brain Tumor Center at Duke —Neurosurgeon-in-Chief, Duke University Hospital —Program Director, Division of Neurosurgery/Department of Surgery
Duke University Medical Center DUMC Box 3807 Durham, NC 27710 Tel: (919) 681-6421 Fax: (919) 681-7872 fried010@mc.duke.edu |
“Malignant brain tumors have ruined the lives of many healthy, vibrant members of our society. We are translating research into successful new treatments —the odds are in our favor for major achievement and long-term answers.” |
|
Allan H. Friedman, MD, is an internationally recognized tumor and vascular neurosurgeon. He has a career-long interest in neuro-oncology, is responsible for over ninety percent of all tumor resections and biopsies conducted at Duke, and has written hundreds of articles on the neurosurgical management of brain tumors and vascular lesions. He is head of the Laboratory of Neurosurgical Oncology and an Associate Chief of the Preuss Laboratory for Brain Tumor Research.
Dr. Friedman's CV |
|
Recent Publications:
Shamji MF,Chen J,Friedman AH,Richardson WJ,Chilkoti A,Setton LA. Synthesis and characterization of a thermally-responsive tumor necrosis factor antagonist.,May 01,2008, (-) - Journal of controlled release : official journal of the Controlled Release Society Abstract [More ...]
Everson RG,Graner MW,Gromeier M,Vredenburgh JJ,Desjardins A,Reardon DA,Friedman HS,Friedman AH,Bigner DD,Sampson JH. Immunotherapy against angiogenesis-associated targets: evidence and implications for the treatment of malignant glioma.,May 01,2008, (717-32) - Expert review of anticancer therapy Abstract [More ...]
Sampson JH,Akabani G,Archer GE,Berger MS,Coleman RE,Friedman AH,Friedman HS,Greer K,Herndon Ii JE,Kunwar S,McLendon RE,Paolino A,Petry NA,Provenzale JM,Reardon DA,Wong TZ,Zalutsky MR,Pastan I,Bigner DD. Intracerebral infusion of an EGFR-targeted toxin in recurrent malignant brain tumors.,Apr 10,2008, (-) - Neuro-oncology Abstract [More ...]
Choi JD,Powers CJ,Vredenburgh JJ,Friedman AH,Sampson JH. Cryptococcal meningitis in patients with glioma: a report of two cases.,Apr 09,2008, (-) - Journal of neuro-oncology Abstract [More ...]
Shamji MF,Whitlatch L,Friedman AH,Richardson WJ,Chilkoti A,Setton LA. An injectable and in situ-gelling biopolymer for sustained drug release following perineural administration.,Apr 01,2008, (748-54) - Spine Abstract [More ...]
Reardon DA,Desjardins A,Vredenburgh JJ,Sathornsumetee S,Rich JN,Quinn JA,Lagattuta TF,Egorin MJ,Gururangan S,McLendon R,Herndon Ii JE,Friedman AH,Salvado AJ,Friedman HS. Safety and pharmacokinetics of dose-intensive imatinib mesylate plus temozolomide: Phase 1 trial in adults with malignant glioma.,Mar 21,2008, (-) - Neuro-oncology Abstract [More ...]
Reardon DA,Zalutsky MR,Akabani G,Coleman RE,Friedman AH,Herndon JE 2nd,McLendon RE,Pegram CN,Quinn JA,Rich JN,Vredenburgh JJ,Desjardins A,Guruangan S,Boulton S,Raynor RH,Dowell JM,Wong TZ,Zhao XG,Friedman HS,Bigner DD. A pilot study: 131I-Antitenascin monoclonal antibody 81c6 to deliver a 44-Gy resection cavity boost.,Feb 20,2008, (-) - Neuro-oncology Abstract [More ...]
Selznick LA,Shamji MF,Fecci P,Gromeier M,Friedman AH,Sampson J. Molecular strategies for the treatment of malignant glioma-genes, viruses, and vaccines.,Feb 08,2008, (-) - Neurosurgical review Abstract [More ...]
Zalutsky MR,Reardon DA,Akabani G,Coleman RE,Friedman AH,Friedman HS,McLendon RE,Wong TZ,Bigner DD. Clinical Experience with {alpha}-Particle Emitting 211At: Treatment of Recurrent Brain Tumor Patients with 211At-Labeled Chimeric Antitenascin Monoclonal Antibody 81C6.,Dec 12,2007, (-) - Journal of nuclear medicine : official publication, Society of Nuclear Medicine Abstract [More ...]
Brown AJ,Friedman AH. Challenges and opportunities for recruiting a new generation of neurosurgeons.,Dec 01,2007, (1314-9; discussion 1319-21) - Neurosurgery Abstract [More ...] |
NOTE: For more publications on this researcher, please visit Pubmed - A service of the National Library of Medicine and the National Institutes of Health.
Back to top
|
|